Compare ISD & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ISD | NUS |
|---|---|---|
| Founded | 2012 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.5M | 469.0M |
| IPO Year | N/A | 1996 |
| Metric | ISD | NUS |
|---|---|---|
| Price | $13.35 | $7.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 99.2K | ★ 513.8K |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | ★ 9.69% | 3.35% |
| EPS Growth | N/A | ★ 207.80 |
| EPS | N/A | ★ 3.18 |
| Revenue | N/A | ★ $3,176,718,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.14 |
| P/E Ratio | ★ N/A | $2.25 |
| Revenue Growth | N/A | ★ 48.98 |
| 52 Week Low | $11.82 | $5.32 |
| 52 Week High | $14.79 | $14.62 |
| Indicator | ISD | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 20.69 | 28.06 |
| Support Level | N/A | $7.18 |
| Resistance Level | $14.67 | $11.06 |
| Average True Range (ATR) | 0.18 | 0.28 |
| MACD | -0.12 | -0.02 |
| Stochastic Oscillator | 10.00 | 14.50 |
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The fund's primary investment objective is to provide a high level of current income, with its secondary objective being capital appreciation. It invests at least eighty percent of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.